Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
James H. Cavanaugh | Director | 2024-11-13 | 213 | $2.82 | $600.66Buy |
Augustine Lawlor | Chief Operating Officer | 2024-11-13 | 2,136 | $2.82 | $6.02kBuy |
Christopher Mirabelli | Chairman of the Board | 2024-11-13 | 2,136 | $2.82 | $6.02kBuy |
Douglas E. Onsi | CEOCFOPres.GCTreas.Sec. | 2024-11-13 | 2,136 | $2.82 | $6.02kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Perceptive Advisors LLC | 22.12% | 8,476,496 | $4.24M | Insider |
Beigene Ltd | 19.18% | 7,348,437 | $3.67M | Insider |
Gilead Sciences Inc | 13.88% | 5,319,148 | $2.66M | Insider |
Healthcare Ventures IX LP | 10.82% | 4,144,804 | $2.07M | Insider |
Balyasny Asset Management LP | 8.05% | 3,085,104 | $1.54M | Institution |
John W. Littlechild | 6.83% | 2,618,406 | $1.31M | Insider |
Samsara Biocapital LLC | 6.37% | 2,442,352 | $1.22M | Institution |
Augustine Lawlor | 4.45% | 1,703,751 | $851.88k | Insider |
Douglas E. Onsi | 3.94% | 1,510,471 | $755.24k | Insider |
Lilly Co Eli | 3.86% | 1,479,307 | $739.65k | Insider |